Not provided
Not provided
Not provided
Not provided
Failure to recruit
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Cystic Fibrosis Trust | OTHER |
| Sport England | OTHER |
| Monash University | OTHER |
Not provided
Not provided
Not provided
Not provided
Increased level of physical activity (PA) are of benefit in the management of cystic fibrosis (CF). This randomised control tial will assess whether three-months use of an online platform can help increase PA levels in people with CF (compared to a control group continuing routine treatment).
Cystic fibrosis (CF) is a genetic condition that predominantly affects the lungs through an accumulation of thick mucus. As there is no cure for CF, it is a disease that is managed through intensive medication, nutrition, physiotherapy, exercise and physical activity (PA).
Increased levels of PA are of benefit to people with CF, and therefore interventions that promote PA are warranted, particularly in adolescence, whereby PA levels decrease. Telehealth interventions are of particular interest in CF, whereby strict cross-infection guidelines prevent patients meeting in person, and allowing patients to overcome geographical barriers at the same time.
Previous research has shown engagement with an online platform (www.activonline.com.au), specifically designed to monitor PA in CF, is feasible and acceptable to people with CF. Therefore, a full randomised control trial is warranted to assess the efficacy of this intervention in changing PA.
UPDATE JUNE 2021: Due to ongoing restrictions placed upon research by the global COVID-19 pandemic, modifications to the protocol are necessary.
Recruitment and consenting will now take place online, and testing procedures will be completed by participants in their own homes. The nature, and length of, intervention remains unchanged.
Changes to protocol approved by ethics board on May 4th 2021.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention | Experimental | Access to online physical activity platform (www.activonline.com.au) in addition to usual care. |
|
| Control | No Intervention | No access to online physical activity platform. Continue with usual care. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| ActivOnline | Behavioral | Access to online physical activity platform (www.activonline.com.au) |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in physical activity, objectively measures using ActiGrpah GT9X Link accelerometer. | Time spent in sedentary, light, moderate and vigorous physical activity domains will be assessed over a one week period. Accelerometer to be worn on non-dominant wrist. | Baseline, post-intervention (+12 weeks), 3-months post-intervention (+24 weeks). |
| Change in physical activity, subjectively measured using the Habitual Activity Estimation Scale. | Questionnaire determines time spent being inactive, somewhat inactive, somewhat active and very active, each reported as a percentage of the day. | Baseline, post-intervention (+12 weeks), 3-months post-intervention (+24 weeks). |
| Measure | Description | Time Frame |
|---|---|---|
| Change in forced expiratory volume in one second (FEV1), measured in absolute units (L) | Assessment of lung function | Baseline, post-intervention (+12 weeks), 3-months post-intervention (+24 weeks). |
| Change in forced vital capacity (FVC), measured in absolute units (L) |
| Measure | Description | Time Frame |
|---|---|---|
| Qualitative assessment of barriers and facilitators to physical activity | Semi-structured, 10-item interview for participants in both intervention and control group | 3-months post-intervention (+24 weeks) |
| Qualitative assessment of Activ Online programme |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Craig A Williams, PhD | University of Exeter | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Exeter | Exeter | Devon | EX1 2LU | United Kingdom |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 25425703 | Background | Cox NS, Alison JA, Button BM, Wilson JW, Holland AE. Feasibility and acceptability of an internet-based program to promote physical activity in adults with cystic fibrosis. Respir Care. 2015 Mar;60(3):422-9. doi: 10.4187/respcare.03165. Epub 2014 Nov 25. | |
| 31856791 | Background | Cox NS, Eldridge B, Rawlings S, Dreger J, Corda J, Hauser J, Button BM, Bishop J, Nichols A, Middleton A, Ward N, Dwyer T, Tomlinson OW, Denford S, Barker AR, Williams CA, Kingsley M, O'Halloran P, Holland AE; Youth Activity Unlimited - A Strategic Research Centre of the UK Cystic Fibrosis Trust. A web-based intervention to promote physical activity in adolescents and young adults with cystic fibrosis: protocol for a randomized controlled trial. BMC Pulm Med. 2019 Dec 19;19(1):253. doi: 10.1186/s12890-019-0942-3. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003550 | Cystic Fibrosis |
| ID | Term |
|---|---|
| D010182 | Pancreatic Diseases |
| D004066 | Digestive System Diseases |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Physical activity intervention. Assignment to intervention or control group cannot be blinded.
Follow-up assessments will be conducted by blinded assessors.
UPADTE JUNE 2021: As noted in update above, all participants will perform procedures themselves within their own homes (i.e. physical activity, lung function, questionnaires). Therefore, use of blinded assessors is no longer applicable.
Not provided
Assessment of lung function |
| Baseline, post-intervention (+12 weeks), 3-months post-intervention (+24 weeks). |
| Change in forced expiratory volume in one second (FEV1), measured as a percent of predicted, as per GLI2012 equations. | Assessment of lung function | Baseline, post-intervention (+12 weeks), 3-months post-intervention (+24 weeks). |
| Change in forced vital capacity (FVC), measured as a percent of predicted, as per GLI2012 equations. | Assessment of lung function | Baseline, post-intervention (+12 weeks), 3-months post-intervention (+24 weeks). |
| Change in exercise attitudes, measured using the Behavioural Regulation in Exercise Questionnaire. | Assessment of reasons underlying people's decision to engage, or not engage, in exercise. Scores range from -24 to +20, where a higher score indicates greater exercise autonomy (better outcome). | Baseline, post-intervention (+12 weeks), 3-months post-intervention (+24 weeks). |
| Change in quality of life, measured using age-specific Cystic Fibrosis Questionnaire (Revised). | Subjective assessment of health related quality of life, scored from 0 to 100 where a higher score indicates higher quality of life (better outcome). | Baseline, post-intervention (+12 weeks), 3-months post-intervention (+24 weeks). |
| Change in anxiety, measured using Hospital Anxiety and Depression Scale. | Subjective report of anxiety, scored from 0 to 21, where a higher score indicates higher anxiety (worse outcome). | Baseline, post-intervention (+12 weeks), 3-months post-intervention (+24 weeks). |
| Change in depression, measured using Hospital Anxiety and Depression Scale. | Subjective report of depression, scored from 0 to 21, where a higher score indicates higher depression (worse outcome). | Baseline, post-intervention (+12 weeks), 3-months post-intervention (+24 weeks). |
| Change in depression, measured using Center for Epidemiological Studies-Depression Scale. | Subjective reports of anxiety and depression, scored from 0 to 60 where a higher score indicates greater depressive symptoms (worse outcome). | Baseline, post-intervention (+12 weeks), 3-months post-intervention (+24 weeks). |
| Change in sleep quality, measured using Pittsburgh Sleep Quality Index (PSQI). | Subjective report of sleep quality, scored from 0 to 21 where a higher score indicates worse sleep quality (worse outcome). | Baseline, post-intervention (+12 weeks), 3-months post-intervention (+24 weeks). |
Semi-structured interview question for participants assigned to intervention group
| 3-months post-intervention (+24 weeks) |
| Usage of Activ Online programme | Frequency of access and logging of physical activity data | Post-intervention (+12 weeks) |
| Changes in physical activity, measured by Sport England Short Active Lives Survey. | Subjective assessment of physical activity | Baseline, post-intervention (+12 weeks), 3-months post-intervention (+24 weeks) |
| Changes in physical activity, measured by Sport England Engagement in Sport Questions | Subjective assessment of physical activity | Baseline, post-intervention (+12 weeks), 3-months post-intervention (+24 weeks) |
| 38577655 | Result | Tomlinson OW, Barker AR, Denford S, Williams CA. Adapting, restarting, and terminating a randomised control trial for people with cystic fibrosis: Reflections on the impact of the COVID-19 pandemic upon research in a clinical population. Contemp Clin Trials Commun. 2024 Mar 27;39:101294. doi: 10.1016/j.conctc.2024.101294. eCollection 2024 Jun. |
| D030342 |
| Genetic Diseases, Inborn |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D007232 | Infant, Newborn, Diseases |